About FOR-ROBIN INC.
For-Robin, Inc. is a biotechnology company founded in 2012 with a mission to develop cancer therapies, named in honor of the founder’s sister who died of breast cancer. The company is preparing an IND for lung cancer imaging in collaboration with NCI NExT for 2023-2024 clinical imaging trials.
Development of monoclonal antibodies (JAA-F11 and humanized variants, hJAA-F11)Targeting all breast and lung cancer cell subtypes, including triple negative breast cancerDevelopment of hJAA-F11 for adjunct therapy of breast and lung cancer as antibody-drug conjugatesPreclinical testing of monoclonal antibodies to the cancer target TF-AgCollaboration with NCI NExT for IND preparation, cGMP production, and FDA interactions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FOR-ROBIN INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.